Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI)
Predicts survival after HCT in patients with hematologic malignancies, including optional age adjustment.
INSTRUCTIONS
Entering age to obtain age-adjusted HCT-CI is optional. The original HCT-CI (without age adjustment) is still considered the standard.
Result:
Please fill out required fields.
Dr. Mohamed Sorror
About the creator
Mohamed Sorror, MD, is an associate professor of medicine at the University of Washington. He is also an associate member of the clinical research division at Fred Hutchinson Cancer Research Center. Dr. Sorror’s research interests are focused on hematological malignancies.
To view Dr. Mohamed Sorror's publications, visit PubMed
Are you Dr. Mohamed Sorror? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
Content Contributors
- Michael Scordo, MD